Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × selpercatinib × Tumor-Agnostic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 5 Endocrine 3 Thoracic 2 Tumor-Agnostic 1 Other 1 Gastrointestinal 1 Breast 1

Conditions

Interventions

Surveys and Questionnaires 70 Blood Specimen Collection 48 Radiotherapy 38 Magnetic Resonance Spectroscopy 35 pembrolizumab 31 Gemcitabine 30 Bevacizumab 30 Nivolumab 29 Carboplatin 29 Radiosurgery 27 Oxaliplatin 26 Capecitabine 25 Standard of Care 24 Paclitaxel 24 Interviews as Topic 24 Cisplatin 24 Fluorouracil 23 Erlotinib Hydrochloride 22 Everolimus 19 Irinotecan 18 Trastuzumab 17 Methods 17 Exercise 17 Docetaxel 17 Biopsy 17 Cyclophosphamide 16 Educational Status 15 Sorafenib 14 Ipilimumab 14 Fluorodeoxyglucose F18 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02925234 2024-01-24

DRUP

The Netherlands Cancer Institute

Phase 2 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡